Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review

References

• ScaleraALoguercioCFocus on irritable bowel syndromeEur Rev Med Pharmacol Sci20121691155117123047498
   PubMed Web of Science ®Google Scholar
• ChangJYTalleyNJAn update on irritable bowel syndrome: from diagnosis to emerging therapiesCurr Opin Gastroenterol2011271727821099429
   PubMed Web of Science ®Google Scholar
• ForteEPizzoferratoMLopetusoLScaldaferriFThe use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromideEur Rev Med Pharmacol Sc2012161253722338545
   PubMed Web of Science ®Google Scholar
• Lesbros-PantoflickovaDMichettiPFriedMBeglingerCBlumALMeta-analysis: the treatment of irritable bowel syndromeAliment Pharmacol Ther20042011–121253126915606387
   PubMed Web of Science ®Google Scholar
• ClavéPAcalovschiMTriantafillidisJKRandomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndromeAliment Pharmacol Ther201134443244221679214
   PubMed Web of Science ®Google Scholar
• Bruley des VarannesSIrritable bowel syndrome: outcome aspectsGastroenterol Clin Biol200933Suppl 1S84S9019303543
   PubMedGoogle Scholar
• MearinFBaroERosetMClinical patterns over time in irritable bowel syndrome: symptom instability and severity variabilityAm J Gastroenterol200499111312114687152
   PubMed Web of Science ®Google Scholar
• HahnBWatsonMYanSIrritable bowel syndrome symptom patterns. Frequency, duration and severityDig Dis Sci19984312271527189881504
   PubMed Web of Science ®Google Scholar
• TalleyNJWeaverALZinsmeisterARMeltonLJOnset and disappearance of gastrointestinal symptoms and functional gastrointestinal disordersAm J Epidemiol199213621651771415139
   PubMed Web of Science ®Google Scholar
• KayLJorgensenTJensenKHThe epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factorsJ Intern Med1994236123308021568
   PubMed Web of Science ®Google Scholar
• OwensDMNelsonDKTalleyNJThe irritable bowel syndrome: long term prognosis and the physician-patient interactionAnn Intern Med199512221071127992984
   PubMed Web of Science ®Google Scholar
• GuileraMBalboaAMearinFBowel habit subtypes and temporal patterns in irritable bowel syndrome. Systematic reviewAm J Gastroenterol200510051174118415842596
   PubMed Web of Science ®Google Scholar
• MearinFBadíaXBalboaAPredictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patientsAliment Pharmacol Ther200623681582616556184
   PubMed Web of Science ®Google Scholar
• El-SeragHBPilgrimPSchoenfeldPSystemic review: natural history of irritable bowel syndromeAliment Pharmacol Ther200419886187015080847
   PubMed Web of Science ®Google Scholar
• EvangelistaSBenefits from long-term treatment in irritable bowel syndromeGastroenterol Res Pract2012201293696022272195
   PubMed Web of Science ®Google Scholar
• EvangelistaSQuaternary ammonium derivatives as spasmolytics for irritable bowel syndromeCurr Pharm Des200410283561356815579053
   PubMed Web of Science ®Google Scholar
• EvangelistaSCochetPBrometNCriscuoliMMaggiCAA distribution study with. 14C-otilonium bromide in the rat: evidence for selective tropism for large intestine after oral administrationDrug Metab Dispos200028664364710820135
   PubMed Web of Science ®Google Scholar
• SuttonJAKilminsterSGMouldGPThe clinical pharmacology of single doses of otilonium bromide in healthy volunteersEur J Clin Pharmacol19975253653699272405
   PubMed Web of Science ®Google Scholar
• ShinBSKimJJKimJOral bioavailability and enterohepatic recirculation of otilonium bromide in ratsArch Pharm Res200831111712418277617
   PubMed Web of Science ®Google Scholar
• CataliotoRMTrioloAGiulianiSIncreased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrierJ Pharm Sci20089794087410018200532
   PubMed Web of Science ®Google Scholar
• AmentaFBaroldiPFerranteFAutoradiographic localization of octylonium bromide binding sites in the rat gastrointestinal tractArch Int Pharmacodyn Ther19913115191724144
   PubMedGoogle Scholar
• EvangelistaSGiechettiAChapelainBReceptor binding profile of otilonium bromidePharmacol Research1998382111117
   Web of Science ®Google Scholar
• LindqvistSHernonJSharpPThe colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic cryptsBr J Pharmacol200213771134114212429587
   PubMed Web of Science ®Google Scholar
• Martínez-CutillasMGilVGallegoDMechanisms of action of otilonium bromide in human cultured smooth muscle cells and rat colonic stripsNeurogastroenterol Motil20132512e803e81223941257
   PubMed Web of Science ®Google Scholar
• StregePREvangelistaSLyfordGLSarrMGFarrugiaGOtilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscleNeurogastroenterol Motil200416216717315086870
   PubMed Web of Science ®Google Scholar
• StregePRShaLBeyderAT-type Ca(2+) channel modulation by otilonium bromideAm J Physiol Gastrointest Liver Physiol20102985G706G71320203058
   PubMed Web of Science ®Google Scholar
• SanticioliPZagorodnyukVRenzettiARMaggiCAAntimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colonNaunyn Schmiedebergs Arch Pharmacol1999359542042710498293
   PubMed Web of Science ®Google Scholar
• CiprianiGSanticioliPEvangelistaSEffect of otilonium bromide and ibodutant on the internalization of the NK2 receptor in human colonNeurogastroenterol Motil20112319610220879991
   PubMed Web of Science ®Google Scholar
• TrainiCCiprianiGEvangelistaSChronic treatment with otilonium bromide induces changes in L-type Ca2+ channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coatNeurogastroenterol Motil201325e728e73923901937
   PubMed Web of Science ®Google Scholar
• GallegoDAulíMAleuJEffect of otilonium bromide on contractile patterns in the human sigmoid colonNeurogastroenterol Motil2010226e180e19120367799
   PubMed Web of Science ®Google Scholar
• MartinMTHove-MadsenLJimenezMOtilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colonNeurogastroenterol Motil200416217518315086871
   PubMed Web of Science ®Google Scholar
• CzimmerJSütoGKirályAMózsikGOtilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndromeJ Physiol Paris2001951–615315611595430
   PubMedGoogle Scholar
• NarducciFBassottiGGranataMTColonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromideDig Dis Sci19863132412463948628
   PubMed Web of Science ®Google Scholar
• BattagliaGMorselli-LabateAMCamarriEOtilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week studyAliment Pharmacol Ther19981210100310109798806
   PubMed Web of Science ®Google Scholar
• GlendeMMorselli-LabateAMBattagliaGEvangelistaSExtended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndromeEur J Gastroenterol Hepatol200214121331133812468954
   PubMed Web of Science ®Google Scholar
• BaldiFLonganesiABlasiAClinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in ItalyItal J Gastroenterol1991238 Suppl 160631756285
   PubMedGoogle Scholar
• ChangFYLuCLLuoJCThe evaluation of otilonium bromide treatment in Asian patients with irritable bowel syndromeJ Neurogastroenterol Motil201117440241022148110
   PubMed Web of Science ®Google Scholar
• DefrancePCasiniAA comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical controlItal J Gastroenterol1991238 Suppl 164661756286
   PubMedGoogle Scholar
• MollicaGMannoGOtilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromideClin Ter199214181291341395455
   PubMedGoogle Scholar
• BoeckxstaensGCorazziariESMearinFTackJIBS and the role of otilonium bromideInt J Colorectal Dis201328329530423178991
   PubMed Web of Science ®Google Scholar
• VillagrasaMBoixJHumbertPQuerJCAleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndromeItal J Gastroenterol1991238 Suppl 167701661630
   PubMedGoogle Scholar
• HeadingRBardhanKHollerbachSLanasAFisherIGSystematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome. A European perspectiveAliment Pharmacol Ther200624220723616842449
   PubMed Web of Science ®Google Scholar
• SpinelliAIrritable bowel syndromeClin Drug Invest20072711533
   PubMed Web of Science ®Google Scholar